loader from loading.io

Increasing Access and Representation in Clinical Trials

CANCER BUZZ

Release Date: 08/26/2025

Navigating R/R FL: A Patient Centered Approach show art Navigating R/R FL: A Patient Centered Approach

CANCER BUZZ

Relapsed/refractory follicular lymphoma (R/R FL) is challenging to treat, requiring thoughtful clinical decision-making during treatment selection and sequencing. In this episode, CANCER BUZZ speaks with Benjamin Heyman, MD, hematologist and clinical associate professor at City of Hope, about the importance of individualized care, shared decision-making, clinical trial referrals, and multidisciplinary collaboration. CANCER BUZZ also speaks with Laurie Adami, patient advocate with R/R FL, about her real-world experience with multiple lines of therapy, clinical trials, and patient advocacy. ...

info_outline
1st Guest 6 Years Later show art 1st Guest 6 Years Later

CANCER BUZZ

After 6 years of bringing listeners key insights into the most pressing topics in oncology, ACCC’s podcast, CANCER BUZZ, has gotten a facelift! In this episode, CANCER BUZZ brings back our first podcast guest, Tina Curtis, DNP, MBA, RN, NEA-BC, executive director of cancer services at Froedtert Hospital. In the June 26, 2019, inaugural CANCER BUZZ episode, Dr. Curtis spoke about her institution’s 24-hour, oncology-only urgent care clinic, which earned the cancer program a 2018 ACCC Innovator Award. Today, she’s returned with her colleague Jayme Cotter to share an update on that program,...

info_outline
Championing Lung Cancer Clinical Trials in the VA show art Championing Lung Cancer Clinical Trials in the VA

CANCER BUZZ

US Veterans are at a heightened risk for lung cancer due to service-related exposures. Integrating clinical research into routine oncology care at the US Department of Veterans Affairs (VA) can help bring clinical trials closer to where Veterans live and improve access to cutting edge therapies. In this episode, CANCER BUZZ speaks with Millie Das, MD, chief of oncology at the VA Palo Alto Health Care System, about the collaborations and institutional support that allowed them to launch lung cancer clinical trials and the role industry has played.     “My primary motivation...

info_outline
Exploring FGFR2b in Gastric and GEJ Cancer show art Exploring FGFR2b in Gastric and GEJ Cancer

CANCER BUZZ

Fibroblast growth factor receptor 2 isoform IIIb (FGFR2b) is an emerging biomarker present in about 38% of patients with advanced gastric or gastroesophageal junction (GEJ) adenocarcinoma. In this episode, CANCER BUZZ speaks with Nataliya Uboha, MD, PhD, a medical oncologist at University of Wisconsin Health, about current recommendations for biomarker testing in this population, emerging biomarkers such as FGFR2b, and how multidisciplinary collaboration can ensure patients receive timely biomarker testing. CANCER BUZZ also interviews Wendi Waugh, BS, RT(R)(T), CMD, ODS, FACCC,...

info_outline
Unlocking ESR1 Mutations in Breast Cancer show art Unlocking ESR1 Mutations in Breast Cancer

CANCER BUZZ

In metastatic breast cancer, resistance to therapy remains one of the most challenging aspects to care. A key driver of resistance in hormone receptor-positive, HER2-negative disease is the ESR1 mutation, a genetic change that alters the estrogen receptor and limits the effectiveness of certain standard therapies. In this episode, CANCER BUZZ speaks with Eleonara Teplinsky, MD, FASCO, head of breast and gynecologic medical oncology at Valley-Mount Sinai Comprehensive Cancer Care, about how the ESR1 mutation shapes treatment decisions and explains communication strategies, such as the...

info_outline
Retired Nurses Supporting the Workforce show art Retired Nurses Supporting the Workforce

CANCER BUZZ

Una Hopkins, DNP, MSN, FNP-BC, NE-BC, RN, FACCC, president of the Association of Cancer Care Centers (ACCC) designated her theme for the 2025-2026 year as in response to forecasts predicting both patient and survivor populations will grow in coming years. In this episode, CANCER BUZZ speaks with Dr. Hopkins about the importance of peer-to-peer mentorship in workforce development and empowerment, particularly for nurses, and why retired nurses are well-equipped to provide this mentorship. Later in the episode, CANCER BUZZ speaks with Josephine Lisowski, RN, BSN, OCN, PRN nurse at Advocate...

info_outline
LIVE from NOC: Women Leaders in Oncology show art LIVE from NOC: Women Leaders in Oncology

CANCER BUZZ

Synopsis: Live this week from the ACCC 42nd National Oncology Conference (NOC), CANCER BUZZ speaks with Dr. Deirdre Saulet, who discusses highlights from Friday morning’s panel session: Women Leaders in Oncology: Exploring Successful Dyad Models.  Guest:  Deirdre Saulet, PhD Chief Strategy Officer Jasper Health   Resources:   

info_outline
LIVE from NOC: Hot Topics show art LIVE from NOC: Hot Topics

CANCER BUZZ

Live this week from the ACCC 42nd National Oncology Conference (NOC), CANCER BUZZ catches up with attendees who highlight takeaways from this year’s hot topic sessions. Guests:  Laura Kuzma  Administrative Director FirstHealth of the Carolinas   Brittany McArn, OPN-CG, CPPN Financial Navigation Manager Outpatient Oncology Services FirstHealth of the Carolinas     Resources:   

info_outline
LIVE from NOC:Serving a Growing Patient Population show art LIVE from NOC:Serving a Growing Patient Population

CANCER BUZZ

Live this week from the ACCC 42nd National Oncology Conference (NOC), CANCER BUZZ shares highlights from the President’s Fireside Chat, where Una Hopkins leads a dynamic conversation with oncology providers from 3 cancer programs that are designing innovative care models to meet the needs of a growing patient population. Speakers:  Dr. Una Hopkins President, ACCC Director, Nursing Research Montefiore Einstein Comprehensive Cancer Center   Karla Bowen Director, Nursing Operations Orlando Health Cancer Institute   Brian Lasonde Advanced Practice Clinician Manager for Medical...

info_outline
LIVE from NOC: Psychosocial Care, Alcohol, Marijuana and more show art LIVE from NOC: Psychosocial Care, Alcohol, Marijuana and more

CANCER BUZZ

Live this week from the ACCC’s 42nd National Oncology Conference (NOC), CANCER BUZZ speaks with ACCC Board of Trustees member Jennifer Bires, who details the highlights from the Wednesday panel discussion she led, “POPS: Navigating Quality Integrative Cancer Support Resources.” Guest:  , MSW, LCSW, OSW-C, FACCC Executive Director, Life with Cancer and Patient Experience Inova Health System, Fairfax Hospital Inova Schar Cancer Institute Fairfax, VA   Resources:   

info_outline
 
More Episodes

Clinical trials are vital to offering and developing the most effective treatment options. However, there are large disparities in enrollment across race, ethnicity, geography, and type of cancer care center. Mary Bird Perkins Cancer Center in Baton Rouge, LA uses local partnerships, culturally tailored outreach, and workforce innovation to drive sustainable and equitable participation in clinical trials. Minorities now make up 21% of their clinical trial participation, surpassing the national average. Following these meaningful gains in attracting local minority populations and underserved communities to take part in clinical trials, the Mary Bird Perkins research team received a grant to further support this work. In this episode of CANCER BUZZ, Victor Lin, MD, PhD, research medical director at Mary Bird Perkins Cancer Center, shares strategies for success in their community, including awareness campaigns and partnerships. CANCER BUZZ also speaks with TaeJeanne “TJ” Taylor-Lawrence, RN, registered nurse and patient navigator, about building relationships and supporting patients in clinical trials.  

 

“We really, really have to be thinking, from a trial design standpoint, about the barriers that we're throwing up in the name of trying to keep the science and the data clean.” - Victor Lin, MD, PhD 

 

“There's been this long-standing perception that cancer clinical trials are really the domain of only academic cancer centers. But I think increasingly we're finding that ... community cancer centers can be more nimble and are perfectly capable of running the same trials and seeing these patients where they live.” - Victor Lin, MD, PhD 

 

“I think that representation builds trust. If people don't see themselves in this process, whether it's in the data, whether it's in the staff, or any of the outreach programs that we have, they're just less likely to believe that this is for them. In my community, black and brown communities especially, I think there's a deep need to feel seen, respected, and understood. When a patient sees someone that looks like them or shares their background talking about clinical trials, I think that that shifts the energy.” - TaeJeanne “TJ” Taylor-Lawrence, RN 

 

“If the research does not reflect all of us, the solutions won't either.” - TaeJeanne “TJ” Taylor-Lawrence, RN 

 

Victor Lin, MD, PhD

Research Medical Director

Mary Bird Perkins Cancer Center

Baton Rouge, LA

 

TaeJeanne “TJ” Taylor-Lawrence, RN

Registered Nurse

Mary Bird Perkins Cancer Center

Baton Rouge, LA

 

Resources:

ACCC Community Oncology Research Institute (ACORI)

Bringing Cancer Research to the Community:  Strategic Approaches to Representative Oncology Clinical Trial Design

Mary Bird Perkins Cancer Center Receives $400,000 Grant to Continue Expansion of Nationally-Recognized Clinical Trials Program